The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Influenza Vaccines: Challenges and Solutions
Open accessAbstract
Vaccination is the best method for the prevention and control of influenza. Vaccination can reduce illness and lessen severity of infection. This review focuses on how currently licensed influenza vaccines are generated in the U.S., why the biology of influenza poses vaccine challenges, and vaccine approaches on the horizon that address these challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Mapping the Antigenic and Genetic Evolution of Influenza Virus
Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2004) · Science · doi:10.1126/science.1097211 · Cited by 1,868
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789 · cited 1×
“Licensed seasonal TIV and LAIV displayed a mean efficacy of 60% in healthy adults and 83% in children, respectively in recent meta-analyses (Ohmit et al., 2013; Osterholm et al., 2012).”
BackgroundGrohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
New World Bats Harbor Diverse Influenza A Viruses
Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., Gomez, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003657 · Cited by 1,351
A distinct lineage of influenza A virus from bats
Tong, S., Li, Y., Rivailler, P., Conrardy, C., Castillo, D. A. A., Chen, L.-M., Recuenco, S., Ellison, J. A., Davis, C. T., York, I. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116200109 · Cited by 1,103
Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
Taubenberger, J. K., & Kash, J. C. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.009 · Cited by 941
Cellular immune correlates of protection against symptomatic pandemic influenza
Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013) · Nature Medicine · doi:10.1038/nm.3350 · Cited by 862
Systems biology of vaccination for seasonal influenza in humans
Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G.-M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2067 · Cited by 809
Self-citationBroadly Neutralizing Antiviral Antibodies
Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 475
Cited by
Paules, C., & Subbarao, K. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30129-0 · Cited by 740
Self-citationBahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642
“This process takes several months and relies on the availability of sufficient supplies of pathogen-free eggs and adaptation of the virus to grow within its substrate.(16,17) The 5–6 months required to produce enough vaccine to protect a substantial proportion of the population consumes much of the duration of the oft…”
BackgroundSecondary bacterial infections associated with influenza pandemics
Morris, D. E., Cleary, D. W., & Clarke, S. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01041 · Cited by 576
Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement
Dou, D., Revol, R., Östbye, H., Wang, H., & Daniels, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01581 · Cited by 564
Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
Kadam, R. U., & Wilson, I. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617020114 · Cited by 435
After the pandemic: perspectives on the future trajectory of COVID-19
Telenti, A., Arvin, A., Corey, L., Corti, D., Diamond, M. S., García-Sastre, A., Garry, R. F., Holmes, E. C., Pang, P. S., & Virgin, H. W. (2021) · Nature · doi:10.1038/s41586-021-03792-w · Cited by 426
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz-Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 402
Jamison, A. M., Quinn, S. C., & Freimuth, V. S. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.12.020 · Cited by 384
Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview
Mostafa, A., Abdelwhab, E. M., Mettenleiter, T. C., & Pleschka, S. (2018) · Viruses · doi:10.3390/v10090497 · Cited by 290
Biological sex affects vaccine efficacy and protection against influenza in mice
Fink, A. L., Engle, K., Ursin, R. L., Tang, W.-Y., & Klein, S. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805268115 · Cited by 253
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Chivukula, S., Plitnik, T., Tibbitts, T., Karve, S., Dias, A., Zhang, D., Goldman, R., Gopani, H., Khanmohammed, A., Sarode, A., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00420-6 · Cited by 117
To, E. E., Erlich, J. R., Liong, F., Luong, R., Liong, S., Esaq, F., Oseghale, O., Anthony, D., McQualter, J., Bozinovski, S., et al. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7727 · Cited by 88
Metadata
- Authors
- Houser, K., & Subbarao, K.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 17
- Issue
- 3
- Pages
- 295-300
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2102847125
- Cited by
- 311
- References
- 46
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.